Nabriva Therapeutics plc

  • TickerNBRV
  • ISINIE00BYQMW233
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryIreland

Analysts

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for NBRV

ValuEngine Rating and Forecast Report for NBRV

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

1 director bought

A director at Nabriva Therapeutics plc bought 50,000 shares at 1.790USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The nam...

ValuEngine Rating and Forecast Report for NBRV

ValuEngine Rating and Forecast Report for NBRV

ValuEngine Rating and Forecast Report for NBRV

ValuEngine Rating and Forecast Report for NBRV

ValuEngine Rating and Forecast Report for NBRV

ValuEngine Rating and Forecast Report for NBRV

ValuEngine Rating and Forecast Report for NBRV

ValuEngine Rating and Forecast Report for NBRV

ValuEngine Rating and Forecast Report for NBRV

ValuEngine Rating and Forecast Report for NBRV

ResearchPool Subscriptions

Get the most out of your insights

Get in touch